arginine has been researched along with Systolic Heart Failure in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delfraino, B; Hazen, SL; Hu, B; Klein, AL; Levison, BS; Shrestha, K; Tang, WH; Tong, W; Troughton, RW; Wang, Z | 1 |
Boni, A; Dini, FL; Fontanive, P; Iurato, A; Piccioni, L; Saponati, G; Volterrani, C | 1 |
Borowski, AG; Hazen, SL; Moravec, CS; Shao, Z; Shrestha, K; Sweet, W; Tang, WH; Thakur, A; Thomas, JD; Wang, Z | 1 |
Billecke, SS; D'Alecy, LG; Marcovitz, PA | 1 |
Borowski, AG; Schuster, A; Tang, WH; Thakur, A; Thomas, JD; Wang, Z | 1 |
Balderas-Munoz, K; Becerra-Luna, B; Castillo-Martínez, L; Infante-Vázquez, O; Keirns-Davis, C; Martínez-Memije, R; Orea-Tejeda, A; Sánchez-Vidal, G; Utrera-Lagunas, M | 1 |
Hazen, SL; Klein, AL; Shrestha, K; Tang, WH; Troughton, RW; Wang, Z | 1 |
2 trial(s) available for arginine and Systolic Heart Failure
Article | Year |
---|---|
Effects of L-arginine on the Minnesota Living with Heart Failure Questionnaire quality-of-life score in patients with chronic systolic heart failure.
Topics: Administration, Oral; Aged; Arginine; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Nitric Oxide; Quality of Life; Stroke Volume; Surveys and Questionnaires; Vasodilation; Ventricular Dysfunction, Left | 2009 |
Improvement of ventricular function in systolic heart failure patients with oral L-citrulline supplementation.
Topics: Administration, Oral; Aged; Arginine; Case-Control Studies; Citrulline; Dietary Supplements; Endothelium, Vascular; Female; Follow-Up Studies; Heart Failure, Systolic; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; Outpatients; Photoplethysmography; Radionuclide Imaging; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2012 |
5 other study(ies) available for arginine and Systolic Heart Failure
Article | Year |
---|---|
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.
Topics: Arginine; Biomarkers; Chronic Disease; Diastole; Disease Progression; Echocardiography, Doppler; Electrocardiography; Female; Heart Failure, Systolic; Humans; Male; Methylation; Middle Aged; Natriuretic Peptides; Nitric Oxide; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Tandem Mass Spectrometry; Treatment Outcome; Ventricular Remodeling | 2008 |
Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.
Topics: Aged; Amidohydrolases; Arginine; Disease Progression; Female; Heart Failure, Systolic; Humans; Hypertension, Pulmonary; Male; Middle Aged | 2012 |
Potential treatment influences and mechanisms related to asymmetric dimethylarginine control in heart failure.
Topics: Amidohydrolases; Arginine; Female; Heart Failure, Systolic; Humans; Hypertension, Pulmonary; Male | 2012 |
Increased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension.
Topics: Arginine; Biomarkers; Endothelium, Vascular; Exercise; Exercise Test; Exhalation; Female; Heart Failure, Systolic; Humans; Hypertension, Pulmonary; Male; Middle Aged; Multivariate Analysis; Nitric Oxide; Oxidative Stress; Surveys and Questionnaires; Time Factors; Ultrasonography | 2012 |
Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.
Topics: Adult; Aged; Arginine; Biological Availability; Biomarkers; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Heart Failure, Systolic; Humans; Male; Middle Aged; Prospective Studies; Risk Factors | 2013 |